Brainstorm Cell Therapeutics Inc.'s (BCLI) CEO Chaim Lebovits on Q1 2022 Results - Earnings Call Transcript

Brainstorm Cell Therapeutics Inc. (NASDAQ:NASDAQ:BCLI) Q1 2022 Earnings Conference Call May 16, 2022 8:00 A.M.

Related Keywords

Boston ,Massachusetts ,United States ,Netherlands ,France ,American ,Kim Thacker ,Michelle Lorenz ,Netta Blondheim Shraga ,Chaim Lebovits ,Tom Galassi ,Billy Dunn ,Daniel Walker ,Antal Pearl Lendner ,David Setboun ,Ralph Kern ,Aaron Gertler ,David Bautz ,Stacy Lindborg ,Company Participants ,Brainstorm Cell Therapeutics Inc ,International Society Of Cell Gene Therapy Conference ,Ge Capital ,Cap Research ,Drug Development Summit ,Research Development ,Nasdaq ,Teva Pharmaceuticals ,American Academy Of Neurology ,Access Program ,International Progressive Ms Alliance ,Brainstorm Cell Therapeutics ,Conference Call May ,Chief Financial ,Vice President ,Chief Development ,Chief Medical ,Chief Operating ,Brainstorm Cell Therapeutics First Quarter ,Alla Patlis ,Interim Chief Financial ,Executive Vice President ,Chief Development Officer ,Chief Medical Officer ,Chief Operating Officer ,American Academy ,Development Summit ,Chief Legal ,Senior Vice President ,Medical Affairs ,Clinical Innovation ,International Society ,Gene Therapy Conference ,Zacks Small Cap ,International Progressive ,